Cookies on this site

RDM’s Dr Daniela Nasteska introduces the colourful world of diabetes research via a brand-new video produced by Oxford Sparks.

Type 2 diabetes is one of the oldest known ailments. In fact, the Indian healer Sushruta described it in the 5th century BC as 'madhumeha', or honey-like urine, when he noticed that urine from sick people attracted ants. Fortunately, medicine has progressed a long way since this time, and Type 2 diabetes is now a condition that can be lived with. So, what actually causes the disease, and how can we treat it?

In the video, Daniela explains how studying islets – small blobs of cells in the pancreas responsible for producing hormones which regulate sugar levels in the body – is the key to understanding more about type 2 diabetes.

Oxford Sparks is the University of Oxford's digital engagement platform for sciences. Find out how you can get involved.
Read more about Daniela's work, funded by Diabetes UK.

Similar stories

Treating iron deficiency: the everyday factors that affect how your supplements work

Hal Drakesmith, Professor of Iron Biology, writes an article for The Conversation exploring how everyday factors can influence the effectiveness of iron supplements.

Type 1 diabetes research centre at University of Oxford marks its first year

Scientists and clinicians are making progress towards a better future for people affected by type 1 diabetes, by exploring how to delay the onset of the condition, develop new treatments, and improve everyday care.

European grant to investigate how tissue ageing influences cancer development

An international team of researchers, including Professor Alison Simmons, has been awarded a €13.97 million Synergy Grant from the European Research Council (ERC) to investigate how ageing in tissues influences the development of cancer.

£520,000 grant to test treatment for haemophilia-related ankle arthritis

Dr Nikki Curry from the Radcliffe Department of Medicine, and Steph Taylor from the Oxford Haemophilia & Thrombosis Centre, have been awarded a clinical trial grant from the National Institute of Health and Care Research for Patient Benefit (NIHR RfPB) funding stream to improve treatment for the ankle arthritis caused by haemophilia.

Researchers highlight need for better sleep support for NHS shift workers

A new study led by researchers at the University of Oxford’s Radcliffe Department of Medicine, has found that many NHS staff working shifts experience sleep difficulties, with researchers calling for more accessible, evidence-based support to help staff manage sleep.

Oxford spin-out raises $90 million to advance new treatments for blood cancers

Alethio Therapeutics, a University of Oxford spin-out co-founded by Professors Adam Mead and Beth Psaila, has secured $90 million (£67 million) in oversubscribed Series A financing to develop a new generation of therapies for myeloproliferative neoplasms (MPNs).

Similar stories

Treating iron deficiency: the everyday factors that affect how your supplements work

Hal Drakesmith, Professor of Iron Biology, writes an article for The Conversation exploring how everyday factors can influence the effectiveness of iron supplements.

Type 1 diabetes research centre at University of Oxford marks its first year

Scientists and clinicians are making progress towards a better future for people affected by type 1 diabetes, by exploring how to delay the onset of the condition, develop new treatments, and improve everyday care.

European grant to investigate how tissue ageing influences cancer development

An international team of researchers, including Professor Alison Simmons, has been awarded a €13.97 million Synergy Grant from the European Research Council (ERC) to investigate how ageing in tissues influences the development of cancer.

£520,000 grant to test treatment for haemophilia-related ankle arthritis

Dr Nikki Curry from the Radcliffe Department of Medicine, and Steph Taylor from the Oxford Haemophilia & Thrombosis Centre, have been awarded a clinical trial grant from the National Institute of Health and Care Research for Patient Benefit (NIHR RfPB) funding stream to improve treatment for the ankle arthritis caused by haemophilia.

Researchers highlight need for better sleep support for NHS shift workers

A new study led by researchers at the University of Oxford’s Radcliffe Department of Medicine, has found that many NHS staff working shifts experience sleep difficulties, with researchers calling for more accessible, evidence-based support to help staff manage sleep.

Oxford spin-out raises $90 million to advance new treatments for blood cancers

Alethio Therapeutics, a University of Oxford spin-out co-founded by Professors Adam Mead and Beth Psaila, has secured $90 million (£67 million) in oversubscribed Series A financing to develop a new generation of therapies for myeloproliferative neoplasms (MPNs).